Inflammatory bowel disease is associated with an increased incidence of cardiovascular events

AJ Yarur, AR Deshpande, DM Pechman… - Official journal of the …, 2011 - journals.lww.com
OBJECTIVES: Patients with inflammatory bowel disease (IBD) present with several
extraintestinal manifestations, including systemic inflammation and hypercoagulability. Limited …

The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study

…, MA Quintero, F Princen, R Kirkland, AR Deshpande… - Gut, 2016 - gut.bmj.com
Objective The aim of this study was to assess the correlation between serum and intestinal
anti-tumour necrosis factor (TNF) levels, and their relationship to endoscopic disease activity …

[HTML][HTML] Low-fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis

…, OM Damas, DH Kerman, AR Deshpande… - Clinical …, 2021 - Elsevier
Background & Aims A high-fat diet has been associated with an increased risk of ulcerative
colitis (UC). We studied the effects of a low-fat, high-fiber diet (LFD) vs an improved standard …

Challenges and possible solutions to colorectal cancer screening for the underserved

…, DS Anderson, L Day, AR Deshpande… - Journal of the …, 2014 - academic.oup.com
Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. CRC incidence
and mortality can be reduced through screening. However, in the United States, screening …

Concentrations of 6-thioguanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy

…, SI Hauenstein, S Lockton, AR Deshpande… - Clinical …, 2015 - Elsevier
Background & Aims In patients with inflammatory bowel diseases, the combination of infliximab
and thiopurines (such as 6-thioguanine) is more effective treatment than monotherapy. …

Digestive manifestations in patients hospitalized with coronavirus disease 2019

…, W Tang, Y Zhang, J Zhu, AR Deshpande… - Clinical …, 2021 - Elsevier
Background & Aims The prevalence and significance of digestive manifestations in
coronavirus disease 2019 (COVID-19) remain uncertain. We aimed to assess the prevalence, …

Higher adalimumab levels are associated with histologic and endoscopic remission in patients with Crohn's disease and ulcerative colitis

…, MA Quintero, JS Barkin, AR Deshpande… - Inflammatory bowel …, 2016 - academic.oup.com
Background Optimal levels of adalimumab (ADA) have not been defined according to the
ultimate goal of inflammatory bowel disease treatment—histologic and/or endoscopic healing. …

[HTML][HTML] Predictors of aggressive inflammatory bowel disease

AJ Yarur, SG Strobel, AR Deshpande… - Gastroenterology & …, 2011 - ncbi.nlm.nih.gov
Inflammatory bowel disease comprises a group of conditions characterized by idiopathic
inflammation of the gastrointestinal tract. The natural course of disease can range from an …

Implementation of a medical student-run telemedicine program for medications for opioid use disorder during the COVID-19 pandemic

…, DP Serota, DW Forrest, AR Deshpande… - Harm reduction …, 2020 - Springer
Objectives The COVID-19 pandemic led to the closure of the IDEA syringe services program
medical student-run free clinic in Miami, Florida. In an effort to continue to serve the …

Phenotypic manifestations of inflammatory bowel disease differ between Hispanics and non-Hispanic whites: results of a large cohort study

…, JL McCauley, L Tamariz, AR Deshpande… - Official journal of the …, 2013 - journals.lww.com
… Jahann; data abstraction: Robert Reznik; study design and editing of the paper: Amar R.
Deshpande and Maria T. Abreu; study design and statistical consultation: Leonardo Tamariz; …